Advertisement
Organisation › Details
DNA Script (Group)
Founded in 2014 in Paris, DNA Script is the world’s leading company in manufacturing de novo synthetic nucleic acids using an enzymatic technology. The company aims at accelerating innovation in life sciences and technology through rapid, affordable, and high-quality DNA synthesis. DNA Script’s approach leverages nature’s billions of years of evolution in synthesizing DNA to enable genome scale synthesis. The Company’s technology has the potential to greatly accelerate the development of new therapeutics, sustainable chemicals production, improved crops as well as data storage. DNA Script recently announced the raise of a Series A financing of $13 million led by Illumina Ventures, with additional investments from M Ventures, the corporate venture arm of Merck KGaA, Darmstadt, Germany, plus existing investors Sofinnova Partners, Kurma Partners, and Idinvest Partners. *
Start | 2014-03-20 established | |
Today | DNA Script SAS | |
Industry | DNA synthesis | |
Industry 2 | enzyme technology | |
Person | Ybert, Thomas (DNA Script 201709 CEO + Co-Founder) | |
Person 2 | Gariel, Sylvain (DNA Script 201709 COO + Co-Founder) | |
Region | Paris | |
Country | France | |
Street | 29 Rue du Faubourg Saint-Jacques | |
City | 75014 Paris | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: | ||
Record changed: 2024-02-12 |
Advertisement
More documents for DNA Script (Group)
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top